Venous access port assembly with X-ray discernable indicia

Description

FIELD OF THE INVENTION

This relates to the field of medical devices and more particularly to venous access ports for the infusion of fluids into a patient and/or withdrawal of fluids from a patient.

BACKGROUND OF THE INVENTION

Venous access ports for the infusion and/or withdrawal of fluids from a patient are well-known, secured to the proximal end of an implanted catheter. These ports are typically used for drug infusion or for withdrawal of small amounts of blood, where large flows of fluid are not required. The ports are assemblies of a needle-impenetrable housing with a discharge port in fluid communication with a catheter and a reservoir within the port housing, and provide a subcutaneous self-sealing septum that defines an access site for multiple needle sticks through the covering skin tissue of the patient, through the septum, and into the reservoir, without the need to continuously search for new access sites. Examples of such ports are disclosed, for example, in U.S. Pat. Nos. 4,704,103; 4,762,517; 4,778,452; 5,185,003; 5,213,574 and 5,637,102.

It is desired to provide a venous access port assembly that provides for a radiologist, radiology technologist, nurse, and ultimately a medical practitioner to be able to discern an important property of the port assembly after the port assembly has been implanted into a patient.

SUMMARY OF THE INVENTION

An embodiment of the present invention is related to a venous access port having a housing and a septum, providing an interior reservoir and a passageway extending from the reservoir through a stem of a discharge port to establish fluid communication with a proximal end of a catheter lumen to which the port assembly is secured prior to placement of the assembly into a patient. The port may optionally have more than one reservoir and associated septum. An embodiment of the present invention includes the incorporation of X-ray discernable indicia onto a venous access port that is discernible under X-ray examination to provide information concerning the nature or key attribute of the venous access port, so that the practitioner, subsequent to the date of implantation thereof, can determine that nature or key attribute under X-ray examination. One such key attribute in particular would be for example that the venous access port is rated to be used for power injection such as of contrast fluid, wherein for example the letters “CT” (for “computed tomography”, or “contrast enhanced computed tomography”) would be provided that are of radiopaque material, or are cutouts through radiopaque material. The attribute in this example is the property of the port being adapted to withstand high pressures that are used for injection of contrast fluid into a patient, and the letters “CT” would be understood in medical practice to indicate that the port is suitable for the high pressure injection of contrast fluid.

In one embodiment, a disc of radiopaque material includes cutouts of letters “CT” (although other indicia may be utilized) through the body of the disc. In another embodiment, discrete letters “CT” (although other indicia may be utilized) are provided of radiopaque material. With either embodiment, the disc or letters may be insert molded within the housing base bottom wall, or they may be affixed to the bottom surface of the housing base, preferably within complementary recesses thereinto, in such a manner that the letters “CT” are readable from above the port assembly in an X-ray.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain the features of the embodiments of the invention. In the drawings:

FIGS. 1 and 2 are an isometric view and a plan view of a venous access port, in accordance with an exemplary embodiment of the present invention;

FIGS. 3 and 4 are cross-sectional views of the port of FIGS. 1 and 2 taken along lines 3-3 and lines 4-4 of FIG. 1, respectively;

FIG. 5 is an isometric view of the needle-impenetrable housing base of the venous access port of FIG. 1;

FIGS. 6 and 7 are transverse cross-sectional and longitudinal cross-sectional views of the housing base of FIG. 5;

FIG. 8 is an isometric view of a first embodiment of X-ray discernable indicia, being a disc of radiopaque material having letters cut out thereof;

FIGS. 9 to 11 are bottom, cross-sectional, and top views of the port assembly of FIGS. 1 to 7 having the disc of FIG. 8 affixed to the housing base of FIGS. 6 and 7 and within a shallow recess into its bottom surface, with silicone covering molded thereover, and the indicia being shown in dashed lines in FIGS. 9 and 11;

FIG. 12 is a cross-sectional view of an alternate embodiment of the housing base having the disc of FIG. 8 insert molded embedded within the bottom wall of the base;

FIG. 13 is an isometric view of a second embodiment of radiopaque indicia, comprising a set of discrete letters of radiopaque material;

FIGS. 14 and 15 are a bottom view and a cross-sectional view of a port assembly of FIGS. 1 to 7 having the discrete letters of FIG. 13 insert molded into the bottom wall of the housing base, with FIG. 15 taken along lines 15-15 of FIG. 13; and

FIGS. 16 to 18 are a bottom view, cross-sectional view, and an isometric bottom view of a port assembly of FIGS. 1 to 7 having the discrete letters of FIG. 13 affixed to the bottom surface of the housing base, shown within respective recesses thereinto, with a silicone covering molded thereover, with FIG. 17 taken along lines 17-17 of FIG. 16.

DETAILED DESCRIPTION OF THE INVENTION

Certain terminology is used herein for convenience only and is not to be taken as a limitation on the present invention. The terms “distal” and “proximal” refer, respectively, to directions closer to and away from the insertion tip of a catheter in an implantable catheter assembly. The terminology includes the words specifically mentioned, derivatives thereof, and words of similar import. The embodiments illustrated below are not intended to be exhaustive or to limit the invention to the precise form disclosed. These embodiments are chosen and described to best explain the principle of the invention and its application and practical use and to enable others skilled in the art to best utilize the invention.

Venous access port assembly 10 of FIGS. 1 to 4 includes a housing 12 and a septum 14, with a discharge port 16 extending from a distal end 18 of the port assembly 10 to be attached securely and sealingly to the proximal end of a catheter (not shown). A passageway 20 extends from the interior reservoir 22 to the distal tip opening 24 of discharge port 16. A recess 26 is seen to be provided along both sides of discharge port 16, facilitating insertion of the discharge port 16 into the catheter lumen and providing a clearance for a locking sleeve or clamp (not shown) utilized to compress the catheter lumen wall against the exterior surface of the discharge port 16 for assured sealed connection of the catheter with the port assembly 10.

With reference now to FIGS. 3 to 7, the interior of the port assembly 10 is shown to provide an interior reservoir 22. Housing 12 is shown to include a housing base 28 of needle-impenetrable material that includes a well 30 having a bottom floor 32 and side walls 34 that define the interior reservoir 22 beneath septum 14. Bottom floor 32 may be convex or elevated (not shown) toward the center of the reservoir, if desired. Housing base 28 includes a base flange 36 extending radially outwardly from the bottom of well 30, and base flange 36 includes openings 38,40 that serve to enable suturing to the patient upon placement of the venous access port and the attached catheter into the patient.

As shown in FIGS. 3 and 4, a skirt 42 is overmolded about housing base 28 and may be of silicone elastomer. It is seen that skirt 42 encapsulates the outer surfaces of the bottom wall 44 and the bottom portion of the side walls 46 of housing base 28, and is shown to fill in the suture holes 38,40; but since the material is silicone elastomer, suturing is possible since the suturing needle can easily be inserted through the material of skirt 42 and through the suture holes, and thereafter the filled openings provide minimal opportunity for ingrowth of patient tissue into the openings.

Also seen in FIGS. 1 to 4 is cap 48, which secures to housing base 28 to in turn secure septum 14 in position in the port assembly 10. Preferably, skirt 42 is insert molded onto base flange 36 of housing base 28 before cap 48 is secured to the upper portion of housing base 28 to secure the septum in position. It is seen in FIGS. 4 and 7 that discharge port 16 is integral with housing base 28 as is preferable. Discharge port 16 is shown to have a pair of annular ridges 50 that facilitate with the mechanical connection of the catheter proximal end with the port assembly 10. Housing base 28 includes a septum seat 52 extending into the top of well 30, into which a flange of the septum will be seated, preferably under radially inward compression. Housing base 28 has a bottom outer surface 54.

FIG. 8 shows a first embodiment of a component of radiopaque material of the present invention in the form of a disc 100, such as of titanium. Cutouts 102 are formed through the disc body, shown in FIG. 8 as the alphabetical letters “CT”. Disc 100 is affixed to the bottom surface 104 of housing base 106 in FIGS. 9 and 10, preferably within a complementary shallow recess 108 thereinto. A skirt 110 of silicone material is molded over the housing base, and is transparent so that the letters “CT” are visible from below but in a mirror-image orientation on the bottom outer surface of the housing base (FIG. 9) so that the indicia would appear as “CT” when the X-ray is viewed (FIG. 11), easily discerned by the radiologist or technologist. Centering of the indicia within the region directly beneath the reservoir and septum minimizes any obscuring by the structure of the venous access port assembly, and the indicia may also be easily discernable should the port assembly be at an angle from the horizontal plane of the X-ray.

In FIG. 12, an alternate embodiment of the present invention is shown, in which the disc 100 of FIG. 8 is embedded within the thickness of the bottom wall 130 of the housing base 132, and the X-ray would appear very similar to that shown in FIG. 11 but the indicia would not be visible from below the housing base or the port assembly.

A second embodiment of X-ray discernable indicia 200 is shown in FIG. 13, and is utilized in the port assemblies of FIGS. 14 to 18. In FIG. 13, the indicia comprise a set of discrete indicia elements 202 of radiopaque material, such as being stamped from a sheet of titanium. Again, as is preferred, the indicia comprise the alphabetical letters “C” and “T” and are utilized together as a set. In FIGS. 14 and 15, the discrete elements are embedded into the thickness of the bottom wall 204 of housing base 206, so that they would not be visible from below (see FIG. 14) even though the silicone overmolded skirt 208 is transparent. However, the discrete letters 202 would clearly be visible on an X-ray very similarly to the port assembly shown in FIG. 11. Another manner of using discrete letters 202 is depicted in FIGS. 16 to 18, in which the letters 202 are insert molded along the bottom surface 230 of housing base 232 and recessed thereinto, preferably. With this variant, the radiopaque material may be titanium or may be, for example, silicone material having barium sulfate filler. In this case the mirror-image of “CT” would be visible from below as depicted in FIG. 18 after the silicone overmolding of skirt 234 about the exterior of housing base 232.

It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.

Claims

1. An implantable venous access port assembly, comprising: a needle-penetrable septum; anda housing securing the needle-penetrable septum, at least a portion of the housing comprising a radiopaque material, at least one cutout defined in at least a portion of the radiopaque material, the at least one cutout forming at least one X-ray discernable indicium indicative of an attribute of the access port assembly.
2. The port assembly of claim 1, wherein the radiopaque material comprises a generally planar portion recessed into a bottom surface of a bottom wall of the housing, the generally planar portion including the at least one cutout.
3. The port assembly of claim 1, wherein: the attribute is a pressure property of the port assembly.
4. The port assembly of claim 3, wherein the pressure property is the port assembly being rated to be used for power injection.
5. The port assembly of claim 3, wherein the pressure property is the port assembly can withstand pressures for injection of contrast fluid.
6. The port assembly of claim 1, wherein the radiopaque material comprises titanium.
7. The port assembly of claim 1, wherein the radiopaque material comprises a polymer with a radiopaque filler.
8. The port assembly of claim 1, wherein the housing further comprises a skirt formed from radiotransparent material molded about at least a portion of the housing.
9. The port assembly of claim 1, wherein the at least one X-ray discernable indicium comprise at least one alphabetical letter.
10. The port assembly of claim 9, wherein the at least one alphabetical letter is at least one of “C” and “T”.
11. The port assembly of claim 1, wherein at least a portion of the housing is made of polysulfone resin.
12. The port assembly of claim 1, wherein the housing and the septum define a reservoir, and at least a portion of the radiopaque material is projecting outward of a periphery of the reservoir.
13. The port assembly of claim 1, wherein the housing comprises entirely of the radiopaque material.
14. The port assembly of claim 1, wherein the housing further comprises a material of different radiopacity from the radiopaque material.
15. An implantable venous access port assembly, comprising: a needle-penetrable septum; anda housing securing the needle-penetrable septum, the housing comprising X-ray discernable indicia formed through a portion of the port assembly, at least one of the X-ray discernable indicia being visible in mirror-image orientation from a bottom of the port assembly.
16. The port assembly of claim 15, wherein the X-ray discernable indicia indicate an attribute of the port assembly.
17. The port assembly of claim 16, wherein the attribute is a pressure property of the port assembly.
18. The port assembly of claim 17, wherein the pressure property is the port assembly being rated to be used for power injection.
19. The port assembly of claim 17, wherein the pressure property is the port assembly can withstand pressure used for injection of contrast fluid.
20. The port assembly of claim 15, further comprising a radiopaque material, wherein the X-ray discernable indicia are formed as at least one cutout in the radiopaque material.
21. The port assembly of claim 20, wherein the radiopaque material comprises titanium.
22. The port assembly of claim 20, wherein the radiopaque material comprises a polymer with a radiopaque filler.
23. The port assembly of claim 20, wherein the housing further comprises a skirt formed from radiotransparent material molded about at least a portion of the housing.
24. The port assembly of claim 20, wherein the radiopaque material comprises a generally planar portion recessed into a bottom surface of a bottom wall of the housing.
25. The port assembly of claim 20, wherein the housing comprises entirely of the radiopaque material.
26. The port assembly of claim 20, wherein the housing comprises a material of different radiopacity from the radiopaque material.
27. The port assembly of claim 15, wherein the X-ray discernable indicia comprise at least one alphabetical letter.
28. The port assembly of claim 27, wherein the at least one alphabetical letter is at least one of “C” and “T”.
29. The port assembly of claim 15, wherein at least a portion of the housing is made of polysulfone resin.
30. The port assembly of claim 15, wherein the housing and the septum define a reservoir, and at least a portion of the X-ray discernable indicia is projecting outward of a periphery of the reservoir.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/251,122, filed Aug. 30, 2016, which is a continuation of Ser. No. 13/088,762, filed Apr. 18, 2011 (now U.S. Pat. No. 9,517,329, issued Dec. 13, 2016), which is a continuation of U.S. patent application Ser. No. 12/175,182, filed Jul. 17, 2008 (now U.S. Pat. No. 8,021,324, issued Sep. 20, 2011), which claims the benefit of U.S. Provisional Application Ser. No. 60/961,133, filed Jul. 19, 2007, and a continuation-in-part of U.S. patent application Ser. No. 11/725,287, filed Mar. 19, 2007, which claims the benefit of U.S. Provisional Application Ser. No. 60/852,591, filed Oct. 18, 2006, the contents of all said applications are incorporated herein by reference.

US Referenced Citations (570)

Number	Name	Date	Kind
574387	Buckler	Dec 1899	A
611357	Dembinski	Dec 1899	A
966696	Merrill	Aug 1910	A
1713267	Crowley	May 1929	A
2029553	Bartschi et al.	Feb 1936	A
2433480	Rendich	Dec 1947	A
2891689	Gould	Jun 1959	A
D198453	Weichselbaum	Jun 1964	S
3293663	Cronin	Dec 1966	A
3341417	Sinaiko	Sep 1967	A
3518428	Ring	Jun 1970	A
3529633	Vaillancourt	Sep 1970	A
3631563	Snowden	Jan 1972	A
3643358	Morderosian	Feb 1972	A
3829904	Ling et al.	Aug 1974	A
3831583	Edmunds et al.	Aug 1974	A
3840009	Michaels et al.	Oct 1974	A
3891997	Herbert	Jul 1975	A
3915162	Miller	Oct 1975	A
3919724	Sanders et al.	Nov 1975	A
3922726	Trentani et al.	Dec 1975	A
3951147	Tucker et al.	Apr 1976	A
4027391	Samis	Jun 1977	A
4035653	Karasko	Jul 1977	A
4121108	Manor	Oct 1978	A
4123806	Amstutz et al.	Nov 1978	A
4168586	Samis	Sep 1979	A
4181132	Parks	Jan 1980	A
4190040	Schulte	Feb 1980	A
4190057	Downie et al.	Feb 1980	A
4194122	Mitchell et al.	Mar 1980	A
4202349	Jones	May 1980	A
4222374	Sampson et al.	Sep 1980	A
4233964	Jefferts et al.	Nov 1980	A
4274006	Caine	Jun 1981	A
4349498	Ellis et al.	Sep 1982	A
4361153	Slocum et al.	Nov 1982	A
4405305	Stephen et al.	Sep 1983	A
4406567	Samis	Sep 1983	A
4425119	Berglund	Jan 1984	A
4445896	Gianturco	May 1984	A
4450592	Niederer et al.	May 1984	A
4450985	Beard	May 1984	A
4456011	Warnecke	Jun 1984	A
4469483	Becker et al.	Sep 1984	A
4494545	Slocum et al.	Jan 1985	A
4506676	Duska	Mar 1985	A
4529635	Sheldon	Jul 1985	A
4543088	Bootman et al.	Sep 1985	A
4549879	Groshong et al.	Oct 1985	A
4559043	Whitehouse et al.	Dec 1985	A
4559046	Groshong et al.	Dec 1985	A
4560375	Schulte et al.	Dec 1985	A
4571749	Fischell	Feb 1986	A
4576595	Aas et al.	Mar 1986	A
4587954	Haber	May 1986	A
4612877	Hayes et al.	Sep 1986	A
4627844	Schmitt	Dec 1986	A
4634427	Hannula et al.	Jan 1987	A
4636194	Schulte et al.	Jan 1987	A
4636213	Pakiam	Jan 1987	A
4645495	Vaillancourt	Feb 1987	A
4653508	Cosman	Mar 1987	A
4655765	Swift	Apr 1987	A
4657024	Coneys	Apr 1987	A
4662652	Hargis	May 1987	A
4668221	Luther	May 1987	A
4671796	Groshong et al.	Jun 1987	A
4673394	Fenton et al.	Jun 1987	A
4684365	Reinicke	Aug 1987	A
4685447	Iversen et al.	Aug 1987	A
4685905	Jeanneret	Aug 1987	A
4692146	Hilger	Sep 1987	A
4695273	Brown	Sep 1987	A
4697595	Breyer et al.	Oct 1987	A
4701166	Groshong et al.	Oct 1987	A
4704103	Stoeber et al.	Nov 1987	A
4710174	Moden et al.	Dec 1987	A
4718894	Lazorthes	Jan 1988	A
4728894	Yoda et al.	Mar 1988	A
4743231	Kay et al.	May 1988	A
4753640	Nichols et al.	Jun 1988	A
4755173	Konopka et al.	Jul 1988	A
4760837	Petit	Aug 1988	A
4762517	Mcintyre et al.	Aug 1988	A
4767410	Moden et al.	Aug 1988	A
4772270	Wiita et al.	Sep 1988	A
4772276	Wiita et al.	Sep 1988	A
4773552	Boege et al.	Sep 1988	A
4778452	Moden et al.	Oct 1988	A
4781680	Redmond et al.	Nov 1988	A
4781685	Lehmann et al.	Nov 1988	A
4781695	Dalton	Nov 1988	A
4802885	Weeks et al.	Feb 1989	A
4804054	Howson et al.	Feb 1989	A
4820273	Reinicke	Apr 1989	A
4822341	Colone	Apr 1989	A
4840615	Hancock et al.	Jun 1989	A
4848346	Crawford	Jul 1989	A
4857053	Dalton	Aug 1989	A
4861341	Woodburn	Aug 1989	A
4863470	Carter	Sep 1989	A
4886501	Johnston et al.	Dec 1989	A
4892518	Cupp et al.	Jan 1990	A
4904241	Bark	Feb 1990	A
4905709	Bieganski et al.	Mar 1990	A
4909250	Smith	Mar 1990	A
4915690	Cone et al.	Apr 1990	A
4928298	Tanaka	May 1990	A
4929236	Sampson	May 1990	A
4955861	Enegren et al.	Sep 1990	A
4963133	Whipple	Oct 1990	A
4966583	Debbas	Oct 1990	A
4973319	Melsky	Nov 1990	A
4983162	Metais et al.	Jan 1991	A
5002735	Alberhasky et al.	Mar 1991	A
5009644	Mcdonald	Apr 1991	A
5013298	Moden et al.	May 1991	A
5041098	Loiterman et al.	Aug 1991	A
5044955	Jagmin	Sep 1991	A
5045060	Melsky et al.	Sep 1991	A
5045064	Idriss	Sep 1991	A
5084015	Moriuchi	Jan 1992	A
5085216	Henley et al.	Feb 1992	A
5090066	Schoepe et al.	Feb 1992	A
5092849	Sampson	Mar 1992	A
5108317	Beinhaur et al.	Apr 1992	A
5108377	Cone et al.	Apr 1992	A
5112301	Fenton et al.	May 1992	A
5112303	Pudenz et al.	May 1992	A
5129891	Young	Jul 1992	A
5137529	Watson et al.	Aug 1992	A
5147483	Melsky et al.	Sep 1992	A
5152753	Laguette et al.	Oct 1992	A
5156600	Young	Oct 1992	A
5158547	Doan et al.	Oct 1992	A
5167629	Vertenstein et al.	Dec 1992	A
5167633	Mann et al.	Dec 1992	A
5167638	Felix et al.	Dec 1992	A
5171228	Mcdonald	Dec 1992	A
5176653	Metals	Jan 1993	A
5176662	Bartholomew et al.	Jan 1993	A
5178612	Fenton, Jr.	Jan 1993	A
5185003	Brethauer	Feb 1993	A
5189690	Samuel	Feb 1993	A
5193106	Desena	Mar 1993	A
5195122	Fabian	Mar 1993	A
5195123	Clement	Mar 1993	A
5201715	Masters	Apr 1993	A
5203771	Melker et al.	Apr 1993	A
5203777	Lee	Apr 1993	A
5213574	Tucker	May 1993	A
5215537	Lynn et al.	Jun 1993	A
5222499	Allen et al.	Jun 1993	A
D337637	Tucker	Jul 1993	S
5224938	Fenton, Jr.	Jul 1993	A
5263930	Ensminger	Nov 1993	A
5281205	Mcpherson	Jan 1994	A
5290263	Wigness et al.	Mar 1994	A
5295658	Atkinson et al.	Mar 1994	A
5299253	Wessels	Mar 1994	A
5309863	Leeb, Jr.	May 1994	A
5312337	Flaherty et al.	May 1994	A
5316545	Cherubini	May 1994	A
5318545	Tucker	Jun 1994	A
5320100	Herweck et al.	Jun 1994	A
5322511	Armbruster et al.	Jun 1994	A
5326460	Cheesman et al.	Jul 1994	A
5328480	Melker et al.	Jul 1994	A
5332398	Miller et al.	Jul 1994	A
5334153	Mcintyre et al.	Aug 1994	A
5336194	Polaschegg et al.	Aug 1994	A
5336398	Russell et al.	Aug 1994	A
5338398	Szwejkowski et al.	Aug 1994	A
5350360	Ensminger et al.	Sep 1994	A
5352204	Ensminger	Oct 1994	A
5360407	Leonard et al.	Nov 1994	A
5363233	Pernick	Nov 1994	A
5383233	Russell	Jan 1995	A
5383858	Reilly et al.	Jan 1995	A
D355240	Gladfelter et al.	Feb 1995	S
5387192	Glantz et al.	Feb 1995	A
5394457	Leibinger et al.	Feb 1995	A
5395324	Hinrichs et al.	Mar 1995	A
5397329	Allen	Mar 1995	A
5399168	Wadsworth et al.	Mar 1995	A
5405402	Dye et al.	Apr 1995	A
5417565	Long	May 1995	A
5417656	Ensminger et al.	May 1995	A
5421814	Geary	Jun 1995	A
5423334	Jordan	Jun 1995	A
5425762	Muller	Jun 1995	A
5429617	Hammersmark et al.	Jul 1995	A
5433480	Gresham et al.	Jul 1995	A
5456698	Byland et al.	Oct 1995	A
5476460	Montalvo	Dec 1995	A
5476880	Cooke et al.	Dec 1995	A
5484402	Saravia et al.	Jan 1996	A
5503630	Ensminger et al.	Apr 1996	A
5507613	Tokiwa	Apr 1996	A
5507813	Dowd et al.	Apr 1996	A
5509805	Jagmin	Apr 1996	A
5513637	Twiss et al.	May 1996	A
5514103	Srisathapat et al.	May 1996	A
5520632	Leveen et al.	May 1996	A
5527277	Ensminger et al.	Jun 1996	A
5527307	Srisathapat et al.	Jun 1996	A
5531684	Ensminger et al.	Jul 1996	A
5556381	Ensminger et al.	Sep 1996	A
5558641	Glantz et al.	Sep 1996	A
5562617	Finch et al.	Oct 1996	A
5562618	Cai et al.	Oct 1996	A
5575770	Melsky et al.	Nov 1996	A
5607393	Ensminger et al.	Mar 1997	A
5607407	Tolkoff et al.	Mar 1997	A
5613945	Cai et al.	Mar 1997	A
5620419	Lui et al.	Apr 1997	A
5632729	Cai et al.	May 1997	A
5637102	Tolkoff et al.	Jun 1997	A
5638832	Singer et al.	Jun 1997	A
5647855	Trooskin	Jul 1997	A
5662600	Watson et al.	Sep 1997	A
5662612	Niehoff	Sep 1997	A
5676146	Scarborough	Oct 1997	A
5695424	Mizuta	Dec 1997	A
5695490	Flaherty et al.	Dec 1997	A
5702128	Maxim et al.	Dec 1997	A
5702363	Flaherty	Dec 1997	A
5704915	Melsky et al.	Jan 1998	A
5709668	Wacks	Jan 1998	A
5713844	Peyman	Feb 1998	A
5713858	Heruth et al.	Feb 1998	A
5713859	Finch et al.	Feb 1998	A
5718382	Jaeger	Feb 1998	A
5718682	Tucker	Feb 1998	A
5725507	Petrick	Mar 1998	A
5733336	Neuenfeldt et al.	Mar 1998	A
5733400	Gore et al.	Mar 1998	A
5741228	Lambrecht et al.	Apr 1998	A
5743873	Cai et al.	Apr 1998	A
5743891	Tolkoff et al.	Apr 1998	A
5746460	Marohl et al.	May 1998	A
5758667	Slettenmark	Jun 1998	A
5769823	Otto	Jun 1998	A
5773552	Hutchings et al.	Jun 1998	A
5776188	Shepherd et al.	Jul 1998	A
5792104	Speckman et al.	Aug 1998	A
5792116	Berg et al.	Aug 1998	A
5810789	Powers et al.	Sep 1998	A
5824071	Nelson et al.	Oct 1998	A
5830172	Leveen et al.	Nov 1998	A
5833654	Powers et al.	Nov 1998	A
5835563	Navab et al.	Nov 1998	A
5836935	Ashton et al.	Nov 1998	A
5840063	Flaherty	Nov 1998	A
5843069	Butler et al.	Dec 1998	A
5853394	Tolkoff et al.	Dec 1998	A
5868702	Stevens et al.	Feb 1999	A
5882353	Vanbeek et al.	Mar 1999	A
5895424	Steele et al.	Apr 1999	A
5906596	Tallarida	May 1999	A
5908414	Otto et al.	Jun 1999	A
5913998	Butler et al.	Jun 1999	A
5916263	Goicoechea et al.	Jun 1999	A
5919160	Sanfilippo, II	Jul 1999	A
5925017	Kriesel et al.	Jul 1999	A
5925030	Gross et al.	Jul 1999	A
5928197	Niehoff	Jul 1999	A
5931829	Burbank et al.	Aug 1999	A
5935084	Southworth	Aug 1999	A
5944023	Johnson et al.	Aug 1999	A
5944688	Lois	Aug 1999	A
5944712	Frassica et al.	Aug 1999	A
5947953	Ash et al.	Sep 1999	A
5951512	Dalton	Sep 1999	A
5951522	Rosato et al.	Sep 1999	A
5954687	Baudino	Sep 1999	A
5957890	Mann et al.	Sep 1999	A
5968011	Larsen et al.	Oct 1999	A
5970162	Kawashima	Oct 1999	A
5989216	Johnson et al.	Nov 1999	A
5989239	Finch et al.	Nov 1999	A
5997524	Burbank et al.	Dec 1999	A
6007516	Burbank et al.	Dec 1999	A
6013051	Nelson	Jan 2000	A
6013058	Prosl et al.	Jan 2000	A
6017331	Watts et al.	Jan 2000	A
6022335	Ramadan	Feb 2000	A
6033389	Cornish	Mar 2000	A
6039712	Fogarty et al.	Mar 2000	A
6077756	Lin et al.	Jun 2000	A
6086555	Eliasen et al.	Jul 2000	A
6090066	Schnell	Jul 2000	A
6102884	Squitieri	Aug 2000	A
6113572	Gailey et al.	Sep 2000	A
6120492	Finch et al.	Sep 2000	A
6161033	Kuhn	Dec 2000	A
6171198	Lizama et al.	Jan 2001	B1
6171298	Matsuura et al.	Jan 2001	B1
6174330	Stinson	Jan 2001	B1
6190352	Haarala et al.	Feb 2001	B1
6193684	Burbank et al.	Feb 2001	B1
6198807	Desena	Mar 2001	B1
6203570	Baeke	Mar 2001	B1
6213973	Eliasen et al.	Apr 2001	B1
6228088	Miller et al.	May 2001	B1
6251059	Apple et al.	Jun 2001	B1
D445175	Bertheas	Jul 2001	S
6269148	Jessop et al.	Jul 2001	B1
6287293	Jones et al.	Sep 2001	B1
6290677	Arai et al.	Sep 2001	B1
6302875	Makower et al.	Oct 2001	B1
6305413	Fischer et al.	Oct 2001	B1
D450115	Bertheas	Nov 2001	S
6332874	Eliasen et al.	Dec 2001	B1
6347241	Burbank et al.	Feb 2002	B2
6355021	Nielsen et al.	Mar 2002	B1
6356782	Sirimanne et al.	Mar 2002	B1
6361557	Gittings et al.	Mar 2002	B1
6396764	Holland	May 2002	B1
6398764	Finch et al.	Jun 2002	B1
6419680	Cosman et al.	Jul 2002	B1
6450937	Mercereau et al.	Sep 2002	B1
6459772	Wiedenhoefer et al.	Oct 2002	B1
6471674	Emig et al.	Oct 2002	B1
6478783	Moorehead	Nov 2002	B1
6482217	Pintor et al.	Nov 2002	B1
6494867	Elver et al.	Dec 2002	B1
6497062	Koopman et al.	Dec 2002	B1
6500155	Sasso	Dec 2002	B2
6503228	Li et al.	Jan 2003	B1
6527754	Tallarida et al.	Mar 2003	B1
6537255	Raines	Mar 2003	B1
RE38074	Recinella et al.	Apr 2003	E
6582418	Verbeek et al.	Jun 2003	B1
6613002	Clark et al.	Sep 2003	B1
6613662	Wark et al.	Sep 2003	B2
6626936	Stinson	Sep 2003	B2
6629950	Levin	Oct 2003	B1
6632217	Harper et al.	Oct 2003	B2
6652486	Bialecki et al.	Nov 2003	B2
6652503	Bradley	Nov 2003	B1
6676633	Smith et al.	Jan 2004	B2
6697664	Kienzle et al.	Feb 2004	B2
6705316	Blythe et al.	Mar 2004	B2
6719721	Okazaki et al.	Apr 2004	B1
6719739	Verbeek et al.	Apr 2004	B2
6738531	Funahashi	May 2004	B1
6755842	Kanner et al.	Jun 2004	B2
6758841	Haarala et al.	Jul 2004	B2
6767356	Kanner et al.	Jul 2004	B2
6784783	Scoggin et al.	Aug 2004	B2
6826257	Sayre et al.	Nov 2004	B2
6852106	Watson et al.	Feb 2005	B2
6878136	Fleury et al.	Apr 2005	B2
6878137	Benchetrit	Apr 2005	B2
6949084	Marggi et al.	Sep 2005	B2
6962580	Adams et al.	Nov 2005	B2
6994315	Ryan et al.	Feb 2006	B2
6997914	Smith et al.	Feb 2006	B2
7008377	Beane et al.	Mar 2006	B2
7008412	Maginot	Mar 2006	B2
7016456	Basu et al.	Mar 2006	B2
7018361	Gillespie et al.	Mar 2006	B2
7044942	Jolly et al.	May 2006	B2
7056316	Burbank et al.	Jun 2006	B1
7070591	Adams et al.	Jul 2006	B2
7072704	Bucholz	Jul 2006	B2
7074232	Kanner et al.	Jul 2006	B2
7076305	Imran et al.	Jul 2006	B2
7083593	Stultz	Aug 2006	B2
7108686	Burke et al.	Sep 2006	B2
7123690	Brown et al.	Oct 2006	B1
7127040	Sayre et al.	Oct 2006	B2
7131962	Estabrook et al.	Nov 2006	B1
7140769	Kay	Nov 2006	B2
7191011	Cantlon	Mar 2007	B2
7198631	Kanner et al.	Apr 2007	B2
7214207	Lynch et al.	May 2007	B2
7214215	Heinzerling et al.	May 2007	B2
7223257	Shubayev et al.	May 2007	B2
7229417	Foerster et al.	Jun 2007	B2
7235067	Morris et al.	Jun 2007	B2
D546440	Burnside	Jul 2007	S
7242982	Singhal et al.	Jul 2007	B2
7252469	Zaluzec et al.	Aug 2007	B2
7252649	Sherry	Aug 2007	B2
7261705	Edoga et al.	Aug 2007	B2
D554253	Kornerup	Oct 2007	S
7275682	Excoffier et al.	Oct 2007	B2
7276075	Callas et al.	Oct 2007	B1
D556153	Burnside	Nov 2007	S
7306579	Fujii	Dec 2007	B2
7311702	Tallarida et al.	Dec 2007	B2
7318816	Bobroff et al.	Jan 2008	B2
7318818	Yashiro et al.	Jan 2008	B2
7322953	Redinger	Jan 2008	B2
D562443	Zinn et al.	Feb 2008	S
7331130	Schweikert	Feb 2008	B2
7331948	Skarda	Feb 2008	B2
7333013	Berger	Feb 2008	B2
D564449	Dewberry	Mar 2008	S
7347838	Kulli	Mar 2008	B2
7347843	Adams et al.	Mar 2008	B2
7351233	Parks	Apr 2008	B2
7377915	Rasmussen et al.	May 2008	B2
D574950	Zawacki et al.	Aug 2008	S
7413564	Morris et al.	Aug 2008	B2
D578203	Bizup	Oct 2008	S
7445614	Bunodiere et al.	Nov 2008	B2
D582032	Bizup et al.	Dec 2008	S
7465847	Fabian	Dec 2008	B2
D595892	Smith et al.	Jul 2009	S
7563025	Kay	Jul 2009	B2
D612479	Zawacki et al.	Mar 2010	S
7713251	Tallarida et al.	May 2010	B2
7785302	Powers	Aug 2010	B2
7833281	Lehman et al.	Nov 2010	B2
8021324	Bizup et al.	Sep 2011	B2
8025639	Powers et al.	Sep 2011	B2
8257325	Schweikert et al.	Sep 2012	B2
8382723	Powers et al.	Feb 2013	B2
8475417	Powers et al.	Jul 2013	B2
8545460	Beasley et al.	Oct 2013	B2
8585663	Powers et al.	Nov 2013	B2
8603052	Powers et al.	Dec 2013	B2
8805478	Powers et al.	Aug 2014	B2
9517329	Bizup et al.	Dec 2016	B2
9682186	Powers et al.	Jun 2017	B2
10052470	Powers et al.	Aug 2018	B2
10179230	Powers et al.	Jan 2019	B2
10183157	Powers et al.	Jan 2019	B2
10625065	Powers et al.	Apr 2020	B2
20010016717	Haarala et al.	Aug 2001	A1
20010051766	Gazdzinski	Dec 2001	A1
20010053889	Marggi et al.	Dec 2001	A1
20010056266	Tallarida et al.	Dec 2001	A1
20020095205	Edwin et al.	Jul 2002	A1
20020138068	Watson et al.	Sep 2002	A1
20020173769	Gray et al.	Nov 2002	A1
20030010929	Priewe et al.	Jan 2003	A1
20030028173	Forsberg	Feb 2003	A1
20030032918	Quinn	Feb 2003	A1
20030060842	Chin et al.	Mar 2003	A1
20030130627	Smith et al.	Jul 2003	A1
20030139812	Garcia et al.	Jul 2003	A1
20030181878	Tallarida et al.	Sep 2003	A1
20030191452	Meglin et al.	Oct 2003	A1
20040002693	Bright et al.	Jan 2004	A1
20040006316	Patton	Jan 2004	A1
20040019356	Fraser et al.	Jan 2004	A1
20040020462	Sauler et al.	Feb 2004	A1
20040044306	Lynch et al.	Mar 2004	A1
20040054352	Adams et al.	Mar 2004	A1
20040056266	Suh et al.	Mar 2004	A1
20040064110	Forsell	Apr 2004	A1
20040073196	Adams et al.	Apr 2004	A1
20040093069	Priewe et al.	May 2004	A1
20040106878	Skujins et al.	Jun 2004	A1
20040106891	Langan et al.	Jun 2004	A1
20040157952	Soffiati et al.	Aug 2004	A1
20040158207	Hunn et al.	Aug 2004	A1
20040167543	Mazzocchi et al.	Aug 2004	A1
20040176743	Morris et al.	Sep 2004	A1
20040181186	Gellman et al.	Sep 2004	A1
20040199129	Dimatteo	Oct 2004	A1
20040199220	Cantlon	Oct 2004	A1
20040204692	Eliasen	Oct 2004	A1
20040225254	Tanaka et al.	Nov 2004	A1
20040254536	Conlon et al.	Dec 2004	A1
20040254537	Conlon et al.	Dec 2004	A1
20050038390	Fago et al.	Feb 2005	A1
20050049553	Triplett et al.	Mar 2005	A1
20050070875	Kulessa	Mar 2005	A1
20050075614	Bunodiere et al.	Apr 2005	A1
20050085723	Huebner	Apr 2005	A1
20050113806	De et al.	May 2005	A1
20050131352	Conlon et al.	Jun 2005	A1
20050148866	Gunderson	Jul 2005	A1
20050148956	Conlon et al.	Jul 2005	A1
20050148957	Girard et al.	Jul 2005	A1
20050152841	Sayre et al.	Jul 2005	A1
20050171502	Daly et al.	Aug 2005	A1
20050182857	Kong	Aug 2005	A1
20050209573	Brugger et al.	Sep 2005	A1
20050215874	Wang et al.	Sep 2005	A1
20050215876	Chen et al.	Sep 2005	A1
20050241203	Lizotte et al.	Nov 2005	A1
20050256451	Adams et al.	Nov 2005	A1
20050256500	Fujii	Nov 2005	A1
20050277899	Conlon et al.	Dec 2005	A1
20050283119	Uth et al.	Dec 2005	A1
20060009788	Freeman et al.	Jan 2006	A1
20060017341	Hahn et al.	Jan 2006	A1
20060084929	Eliasen	Apr 2006	A1
20060089619	Ginggen	Apr 2006	A1
20060100592	Eliasen	May 2006	A1
20060116648	Hamatake	Jun 2006	A1
20060173410	Moberg et al.	Aug 2006	A1
20060173424	Conlon	Aug 2006	A1
20060178647	Stats	Aug 2006	A1
20060184141	Smith et al.	Aug 2006	A1
20060184142	Schon et al.	Aug 2006	A1
20060217359	Wentworth et al.	Sep 2006	A1
20060217659	Patton	Sep 2006	A1
20060224128	Lurvey et al.	Oct 2006	A1
20060224129	Beasley et al.	Oct 2006	A1
20060247584	Sheetz et al.	Nov 2006	A1
20060253076	Butts et al.	Nov 2006	A1
20060264898	Beasley et al.	Nov 2006	A1
20070007839	Lin	Jan 2007	A1
20070049876	Patton	Mar 2007	A1
20070055290	Lober	Mar 2007	A1
20070073250	Schneiter	Mar 2007	A1
20070078391	Wortley et al.	Apr 2007	A1
20070078416	Eliasen	Apr 2007	A1
20070078432	Halseth et al.	Apr 2007	A1
20070083156	Muto et al.	Apr 2007	A1
20070149920	Michels et al.	Jun 2007	A1
20070149921	Michels et al.	Jun 2007	A1
20070161958	Glenn	Jul 2007	A1
20070161985	Demakas et al.	Jul 2007	A1
20070179456	Glenn	Aug 2007	A1
20070185462	Byrum	Aug 2007	A1
20070191773	Wojcik	Aug 2007	A1
20070208313	Conlon et al.	Sep 2007	A1
20070219510	Zinn et al.	Sep 2007	A1
20070233017	Zinn et al.	Oct 2007	A1
20070233018	Bizup et al.	Oct 2007	A1
20070255234	Haase et al.	Nov 2007	A1
20070270691	Bailey et al.	Nov 2007	A1
20070270770	Bizup	Nov 2007	A1
20070276344	Bizup et al.	Nov 2007	A1
20070299408	Alferness et al.	Dec 2007	A1
20080004642	Birk et al.	Jan 2008	A1
20080008654	Clarke et al.	Jan 2008	A1
20080015701	Garcia et al.	Jan 2008	A1
20080039820	Sommers et al.	Feb 2008	A1
20080048855	Berger	Feb 2008	A1
20080108949	Beasley et al.	May 2008	A1
20080114308	Di et al.	May 2008	A1
20080138387	Machiraju	Jun 2008	A1
20080140025	Sheetz et al.	Jun 2008	A1
20080208236	Hobbs et al.	Aug 2008	A1
20080281279	Hoendervoogt et al.	Nov 2008	A1
20080319398	Bizup	Dec 2008	A1
20080319399	Schweikert et al.	Dec 2008	A1
20080319405	Bizup	Dec 2008	A1
20090024024	Zinn	Jan 2009	A1
20090024098	Bizup et al.	Jan 2009	A1
20090035582	Nakatani et al.	Feb 2009	A1
20090118683	Hanson et al.	May 2009	A1
20090156928	Evans et al.	Jun 2009	A1
20090171436	Casanova et al.	Jul 2009	A1
20090199857	Peake et al.	Aug 2009	A1
20090204072	Amin et al.	Aug 2009	A1
20090204074	Powers et al.	Aug 2009	A1
20090221976	Linden	Sep 2009	A1
20090227862	Smith et al.	Sep 2009	A1
20090227951	Powers et al.	Sep 2009	A1
20100004735	Yang et al.	Jan 2010	A1
20100042073	Oster et al.	Feb 2010	A1
20100069743	Sheetz et al.	Mar 2010	A1
20110054312	Bell et al.	Mar 2011	A1
20190134373	Barron et al.	May 2019	A1
20190151641	Powers et al.	May 2019	A1
20190217073	Maniar et al.	Jul 2019	A1
20190252603	Wiley et al.	Aug 2019	A1
20190275311	Hibdon et al.	Sep 2019	A1
20200086105	Powers et al.	Mar 2020	A1

Foreign Referenced Citations (78)

Number	Date	Country
2663853	Apr 2008	CA
2663853	Nov 2014	CA
8437873	Mar 1986	DE
3447202	Jul 1986	DE
19745654	Apr 1999	DE
0619101	Oct 1994	EP
0750520	Aug 2000	EP
1238682	Sep 2002	EP
2081634	Jul 2009	EP
1896117	Jan 2011	EP
3275503	Jan 2018	EP
3311877	Apr 2018	EP
1509165	Jan 1968	FR
2569987	Mar 1986	FR
2586569	Mar 1987	FR
2203342	Oct 1988	GB
2500388	Jun 1996	JP
H08168322	Jul 1996	JP
2602109	Apr 1997	JP
2003102831	Apr 2003	JP
2004350937	Dec 2004	JP
2006500087	Jan 2006	JP
2006025948	Feb 2006	JP
2008168322	Jul 2008	JP
2009004190	Apr 2009	MX
2010000703	Jul 2010	MX
8600213	Jan 1986	WO
9305730	Apr 1993	WO
9514504	Jun 1995	WO
9701370	Jan 1997	WO
9706845	Feb 1997	WO
9711726	Apr 1997	WO
9817337	Apr 1998	WO
9942166	Aug 1999	WO
0004800	Feb 2000	WO
0011726	Mar 2000	WO
0014504	Mar 2000	WO
0017337	Mar 2000	WO
0033901	Jun 2000	WO
0047264	Aug 2000	WO
0047549	Aug 2000	WO
0100480	Jan 2001	WO
0247549	Jun 2002	WO
02100480	Dec 2002	WO
03037215	May 2003	WO
03086508	Oct 2003	WO
2004004800	Jan 2004	WO
2004071555	Aug 2004	WO
2004091434	Oct 2004	WO
2005037055	Apr 2005	WO
2006078915	Jul 2006	WO
2006096686	Sep 2006	WO
2006116438	Nov 2006	WO
2006130133	Dec 2006	WO
2006134100	Dec 2006	WO
2007025266	Mar 2007	WO
2006116438	Mar 2007	WO
2007079024	Jul 2007	WO
2007092210	Aug 2007	WO
2007094898	Aug 2007	WO
2006078915	Sep 2007	WO
2007098771	Sep 2007	WO
2007109164	Sep 2007	WO
2007126645	Nov 2007	WO
2007136538	Nov 2007	WO
2008008126	Jan 2008	WO
2008019236	Feb 2008	WO
2008048361	Apr 2008	WO
2008063226	May 2008	WO
2008147760	Dec 2008	WO
2008157763	Dec 2008	WO
2009002839	Dec 2008	WO
2009012385	Jan 2009	WO
2009012395	Jan 2009	WO
2009035582	Mar 2009	WO
2009046439	Apr 2009	WO
2009046725	Apr 2009	WO
2009108669	Sep 2009	WO

Non-Patent Literature Citations (106)

Entry
9.75/1 0.0 em Lap-Band System vs. 11 em Lap-Band System: For Product Manufactured Prior to Jul. 2001, Lap-Band System Access Port Fill Guide I BioEnterics Corporation, Jul. 1, 2001, 1 page.
Bard Access System Product Drawings Representative of the Bard Access System Products on the Market on or Around Mar. 1995, as Indicated by the Bard Access Systems 1995 Product Release to Market form for “M.R.I. Port with8 Fr. ChronoFiex Catheter,” “M.R.I. Port with 8 Fr. ChronoFiex Catheter with Intro-EzeTM,”, “M.R.I. Port with 8 Fr. Chrono-Flex Catheter and Peel Apart,” “M.R.I. Port with 8 Fr. ChronoFiex Catheter Demo Kit,”, Mar. 21, 1995, 6 pages.
Declaration of Kelly Christian, Director of Product Development at Bard Access Systems, Inc, in Support of and Depicting a Product on the Market by Quinton Company Approximately Ten Years Prior to Oct. 22, 2009, 1 page.
Extravasation of Radiologic Contrast, PA-PSRS Patient Safety Advisory—vol. 1, No. 3, Sep. 2004, 6 pages.
Extreme Access, Bard Access Systems, Inc., Product Brochure, 2003, 5 pages.
Guidance for Industry and FDA Staff, Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use, Nov. 30, 2004, 12 pages.
Guidance for Institutional Review Boards and Clinical Investigators 1998 Update: Medical Devices, U.S. Food and Drug Administration,Version Sep. 10, 2008, 13 pages.
Guidance on Medical Device Patient Labeling; Final Guidance for Industry and FDA Reviewers, Apr. 19, 2001, 54 pages.
International Preliminary Report on Patentability and Written Opinion Received for PCT Patent Application No. PCT/US2006/049007, dated Jul. 1, 2008, 5 pages.
International Preliminary Report on Patentability and Written Opinion Received for PCT Patent Application No. PCT/US2006/008022, dated Sep. 12, 2007, 6 pages.
International Search Report and Written Opinion for PCT Patent Application No. PCT/US2008/078976 , dated Apr. 3, 2009, 6 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US08/067679, dated Sep. 30, 2008, 7 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2008/070330, dated Dec. 1, 2008, 10 pages.
International Search Report Received for PCT Patent Application No. PCT/US06/008022, dated Jul. 5, 2006, 2 pages.
International Search Report Received for PCT Patent Application No. PCT/US06/015695, dated Jan. 11, 2007, 6 pages.
IsoMed Constant-Flow Infusion System (Year: 2000), 111 pages.
Product Specifications, Port-A-Cath P.A.S. Port Systems by Deltec, 1999, 2 pages.
Reminders form FDA Regarding Ruptured Vascular Access Devices from Power Injection, Jul. 2004, 2 pages.
Signs, Symbols, and Icons: Pre-history to the Computer Age, author: Rosemary Sassoon and Albertine Gaur, first published in 1997, 3 pages.
Title User Manual Sprint, Available at http://www. cochlearamericas. com/PDFs/UserManualSprint.pdf, Dec. 1, 2012, 2 Pages.
User Manual for the ESPrit 3G Apeech Processor and Accessories, Nucleus Cochlear Implant Systems; available at <http://www.cochlearamericas.com/PDFs/UserManualSprint.pdf>, Issue 2, Dec. 2001, 2 pages.
Implantable Port Device, U.S. Patent Application filed Sep. 7, 2007, 8 pages.
Bard Access Systems, Inc., “Hickman Subcutaneous Ports & Hickman/Broviac Catheters”, Bard Exhibit, vol. 1017, Jan. 1, 1992.
Bard Access Systems, Inc., “Ports—Setting the Standard with a Comprehensive Family of Ports”, Bard Exhibit vol. 1002, Jan. 1, 2003, pp. 1-17.
Bard Access Systems, Inc., “Power Port—Implantable Port—Feel the New Standard of Care—Guidelines for CT Technologists”, Bard Exhibit 1004, C.R. Bard, Inc., Feb. 1, 2007, 1 Page.
Biffi et al., A Randomized, Prospective Trial of Central Venous Ports Connected to Standard Open-Ended or Groshong Catheters in Adult Oncology Patients, American Cancer Society vol. 92, No. 5, Sep. 1, 2001, pp. 1204-1212.
Biffi et al., Best Choice of Central Venous Insertion Site for the Prevention of Catheter-Related Complications in Adult Patients Who Need Cancer Therapy: A Randomized Trial, Annals of Oncology, 6 Pages.
Biffi et al., Use of Totally Implantable Central Venous Access Ports for High-Dose Chemotherapy and Peripheral Blood Stem Cell Transplantation: Results of a Monocentre Series of 376 Patients, Annals of Oncology vol. 5, Jan. 1, 2004, pp. 296-300.
Biffi, et al., Best Choice of Central Venous Insertion Site for the Prevention of Catheter-Related Complications in Adult Patients Who Need Cancer Therapy: A Randomized Trial., Annals of Oncology, Jan. 29, 2009, 6 pages.
Bioenterics® Lap-Band®, Adjustable Gastric Banding System, by Inamed Health, Product Brochure, Dec. 1, 2003, 22 pages.
Carlson et al., Safety Considerations in the Power Injection of Contrast Media via Central Venous Catheters During Computed Tomographic Examinations, Investigative Radiology, vol. 27, No. 5, May 1992, pp. 337-340.
Costa et al., Understanding Contrast Media, Journal of Infusion Nursing, vol. 27, No. 5, Sep./Oct. 2004, 11 pages.
Costa, Nancy, More Than Skin Deep: An Overview of Iodinated Contrast Media, Journal for the Association for Vascular Access, vol. 8, No. 4, 2003, 6 pages.
Coyle et al., Power Injection of Contrast Media via Peripherally Inserted Central Catheters for CT, The Journal of the Association for Vascular Access (JAVA), vol. 15, No. 8, Aug. 2004, pp. 809-814.
Extended European Search Report received for EP Application No. EP 08781983.5, 5 pages.
Fallscheer et al., Injury to the Upper Extremity Caused by Extravasation of Contrast Medium Medium: A, Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, vol. 41, pp. 26-32, 2007, 7 pages.
Herts et al., Power Injection of Contrast Media Using Central Venous Catheters: Feasibility, Safety and Efficacy, AJR:176(2), Feb. 2001, pp. 447-453.
Herts et al., Power Injection of Intravenous Contrast Material Through Central Venous Catheters for CT: In Vitro Evaluation, Radiology, vol. 200, No. 3, Sep. 1996, pp. 731-735.
Hou et al., Comparisons of Outcomes and Survivals for Two Central Venous Access Port Systems, Journal of Surgical Oncology, vol. 91, Jan. 1, 2005, pp. 61-66.
I Named Health, Adjustable Gastric Banding System, Product Brochure, BioEnterics® Lap-Band®, Dec. 2003, 22 pages.
Johnson Kathleena., Power Injectable Portal Systems, Journal of Radiology Nursing, vol. 28, Issue 1, Mar. 2009, 6 pages.
Lamaitre Vascular, Port Implantations: using the OptiLock Implantable Port, product information, available at <http://www.lemaitre. com/specs_pop.asp>, Apr. 2003, 14 pages.
Lap-Band APTM, System with Adjustable Gastric Banding system with Omniform Design, Product Brochure, Jul. 2007, 16 pages.
Lap-Band®, System Fact Sheet, Allergan, Inc., 2007, 2 pages.
Medcomp, PortCT Technology, Display at SIR Conference, Toronto, Canada, Mar. 2006, 1 page.
Extended European Search Report received for European Patent Application No. 17189436.3 , dated Oct. 13, 2017.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2007/006776, dated Dec. 18, 2007, 3 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2007/006776, dated Jan. 2, 2009, 6 pages.
International Search Report Received for PCT Patent Application No. PCT/US1999/028695, dated Apr. 11, 2000, 2 pages.
International Search Report Received for PCT Patent Application No. PCT/US2009/062854, dated Dec. 23, 2009, 2 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US06/49007, dated Oct. 1, 2007, 6 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US07/006776, dated Dec. 18, 2007, 4 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US08/070345, dated Dec. 1, 2008, 11 pages.
International Search Report Received for PCT Patent Application No. PCT/US2006/008022, dated Jul. 5, 2006, 2 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2006/015695, dated Jan. 11, 2007, 8 pages.
International Preliminary Report on Patentability and Written Opinion Received for PCT Patent Application No. PCT/US2006/016056, dated Oct. 30, 2007, 9 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2006/49007, dated Oct. 1, 2007, 6 pages.
International Preliminary Report on Patentability and Written Opinion Received for PCT Patent Application No. PCT/US2007/006776, 3 pages.
International Preliminary Report on Patentability Received for PCT Application No. PCT/US2007/011015, dated Nov. 23, 2009, 9 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2007/011015, dated Jun. 10, 2008, 5 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2007/011456, dated Aug. 28, 2008, 6 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2008/010520, dated Feb. 24, 2009, 6 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2008/067679, dated Sep. 30, 2008, 7 pages.
International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2008/070345, dated Dec. 1, 2008, 11 pages.
International Search Report Received for PCT Application No. PCT/US2009/062854, dated Dec. 23, 2009, 2 pages.
Plinski et al., Implantable Cardioverter-Defribillators: Implications for the Nonelectrophysiologist, Annals of Internal Medicine, Abstract of vol. 122, No. 10, pp. 770-777.
Port-a-Cath®, Implantable Epidural, Aterial and Peritonial Access Systems, Internet Product Listing of Nov. 19, 2000, available at <http://web. archive.org/web/20001119035900/www.deltec.com/cPacspl.htm,>, Oct. 17, 2009, 2 pages.
Port-a-Cath®, Many Port-a-Cath® System Choices, Product Brochure, SIMS Deltec, Inc., 1996, 5 pages.
Port-a-Cath®, Single-lumen Implantable Vascular Access Systems, Product Specifications Smith Medical, 2004, 4 pages.
Rappolt et al., Radiopaque Codification and X-ray Identification of Ingested Drugs, Ingestive Radioiogy, May-Jun. 1966, 4 pages.
Salis et al., Maximal Flow Rates Possible During Power Injection Through Currently Available PICCs: An In-Vitro Study, Journal of the Association for Vascular Access, vol. 15, No. 3, Mar. 2004, pp. 275-281.
Sandstede Joern, Pediatric CT, Available online at www.multislice- ct.com, MultiSLICE-CT.com, version 02, May 2, 2003, 36 pages.
Sanelli et al., “Safety and Feasibility of Using a Central Venous Catheter for Rapid Contrast Injection Rates”, American Journal of Radiology, vol. 183, Dec. 2004, pp. 1829-1834.
Sawyer Dick, Do It by Design: An Introduction to Human Factors in Medical Devices, U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Devices and Radiological Health, Dec. 1996, 55 pages.
Shah Tilak M., Radiopaque Polymer Formulations for Medical Devices, Medical Device and Diagnostic Industry, Mar. 2000, 6 pages.
Smith Lisa Hartkoph, Implanted Ports, Computer Tomography, Power Injectors, and Catheter Rupture, Clinical Journal of Oncology Nursing, vol. 12, No. 5, Oct. 2008, 4 pages.
Solomon et al., CIN Strategies: Anticipate, Manage, Prevent, Supplement to Imaging Economics, May 1, 2007, 20 Pages.
Steinbach et al., Breast Implants, Common Complications, and Concurrent Breast Disease, RadioGraphies, vol. 13, No. 1, Jan. 1, 1993, pp. 95-118.
Stevens et al., A Randomized, Prospective Trial of Conventional Vascular Ports vs. The Vortex “Clear-Flow” Reservoir Port in Adult Oncology Patients, The Journal of Vascular Access Devices, 2000, pp. 37-40.
Sullivan et al., Radiopaque Markers on Mammary Implants, American Journal of Roentgenology vol. 153(2):428, Aug. 1989, 2 pages.
Teichgraber et al., Central Venous Access Catheters: Radiological Management of Complications, Cardiovascular and Interventional Radiology, Review Article, Jul. 31, 2003, 13 pages.
Thistlethwaite et al., Generalized Feature-Based RSA of Orthopaedic Implants, Summer Bioengineering Conference Sonesta Beach Resort in Key Biscayne, Florida, Jun. 25-29, 2 pages.
Extended European Search Report Received for European Patent Application No. 07753408.9, dated Aug. 24, 2012.
International Preliminary Report on Patentability and Writen Opinion Received for PCT Patent Application No. PCT/US2006/016056, dated Oct. 30, 2007, 9 pages.
International Preliminary Report on Patentability and Written Opinion received for PCT Patent Application No. PCT/US2006/015695, dated Oct. 30, 2007,9 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2007/006776, completed on Nov. 16, 2008, 3 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2007/006776 , dated Mar. 6, 2008, 3 pages.
Urquiola et al., Using Lead Foil as a Radiopaque Marker for Computerized Tomography Imaging When Implant Treatment Planning, The Journal of Prosthetic Dentistry, vol. 77, No. 2, 1997, pp. 227-228.
International Search Report and Written Opinion received for International Patent Application No. PCT/US2012/050586, dated Oct. 22, 2012.
Vergara et al., Adverse Reactions to Contrast Media in CT: Effects of Temperature and Ionic Property, Radiology, vol. 199, No. 2, May 1, 1996, 4 pages.
Vogelzang Robertl., “Power Injection Through Central Venous Catheters: Physiological and Hemodynamic Considerations”, The McGaw Medical Center of Northwestern University, Feinberg School of Medicine, 3 pages.
Wells S, Venous Access in Oncology and Haematology Patients: Part One, Nursing Standard, vol. 22, No. 52, pp. 39-46,, Sep. 3, 2008, 9 pages.
Williamson et al., Assessing the Adequacy of Peripherally Inserted Central Catheters for Power Injection of Intravenous Contrast Agents for CT, Journal of Computer Assisted Tomography, vol. 6, No. 6, 2001, pp. 932-937.
Funaki, “Central Venous Access: A Primer for the Diagnostic Radiologist”, 2002, AJR, 179:309-318.
Cope et al., Access Device Guidelines—Recommendations for Nursing Practice and Education, 2d Edition, 2004, 85 pages.
Gebauer et al., “Contrast Media Power Injection Using Central-Venous Port Catheters—Results of an In Vitro Study”, Experimental Radiology, 2005, 177:1417-1423.
“Radiopaque Imprinting Enables Alternative to Angioplasty”, Medical Product Manufacturing News, Apr. 2003, 1 page.
McKillop et al., “Retained Surgical Swab Misinterpreted as Epicardial Pacing Wire on Chest X Ray”, 1996, Heart, 75:342.
Wolfson et al., “Imaging of Surgical Paraphernalia: What Belongs in the Patient and What Does Not”, 2000, Radiographics, 20:1665-1673.
O'Connor et al., “Imaging of Retained Surgical Sponges in the Abdomen and Pelvis”, 2003, AJR, 180:481-489.
Walter et al., “Radiographic Identification of Commonly Used Implanted Pacemakers”, The New England Journal of Medicine, 1969, vol. 281, 22:1230-1231.
Walter, “Radiographic Identification of Commonly Used Pulse Generators-1970”, 1971, JAMA, vol. 215, 12:1974-1975.
U.S. Appl. No. 60/658,518, filed Mar. 4, 2005, 62 pages.
The extended European search report, dated Mar. 3, 2018, for EP App. No. 17193828.5, which claims priority to U.S. Appl. No. 60/961,133, filed Jul. 19, 2007, 8 pages.
Declaration of Annemarie Boswell, dated Jul. 23, 2005, including Attachment A: Powerport Guidelines for CT Technologists, copyright 2007 Revised date Feb. 2007, 8 pages.
Interference Decision, Zinn vs Powers, Patent Interference No. 105,860, Paper 50, Sep. 11, 2012, 9 pages.

Related Publications (1)

	Number	Date	Country
	20210093847 A1	Apr 2021	US

Provisional Applications (2)

	Number	Date	Country
	60961133	Jul 2007	US
	60852591	Oct 2006	US

Continuations (3)

	Number	Date	Country
Parent	15251122	Aug 2016	US
Child	17122251		US
Parent	13088762	Apr 2011	US
Child	15251122		US
Parent	12175182	Jul 2008	US
Child	13088762		US

Continuation in Parts (1)

	Number	Date	Country
Parent	11725287	Mar 2007	US
Child	12175182		US

Venous access port assembly with X-ray discernable indicia

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

CPC

Field of Search

CPC

International Classifications

Disclaimer

Term Extension

Abstract